- Home
- TBLA vs INMD Comparison
TBLA vs INMD Comparison
Compare TBLA & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TBLA | INMD |
|---|---|---|
| Founded | 2007 | 2008 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 879.2M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | TBLA | INMD |
|---|---|---|
| Price | $3.12 | $13.76 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 6 |
| Target Price | $5.00 | ★ $16.75 |
| AVG Volume (30 Days) | 1.3M | ★ 1.3M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $8.73 | $3.80 |
| Revenue Next Year | $6.16 | $4.79 |
| P/E Ratio | $42.36 | ★ $10.11 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.63 | $13.16 |
| 52 Week High | $4.65 | $19.78 |
Technical Indicators
Market Signals| Indicator | TBLA | INMD |
|---|---|---|
| Relative Strength Index (RSI) | 32.16 | 40.14 |
| Support Level | $3.13 | N/A |
| Resistance Level | $3.71 | $15.02 |
| Average True Range (ATR) | 0.15 | 0.40 |
| MACD | -0.02 | -0.12 |
| Stochastic Oscillator | 40.52 | 3.74 |
Price Performance
Historical ComparisonAbout TBLA Taboola.com Ltd.
Taboola is a performance-based native advertising network designed to improve click-through rates and increase monetizable events for advertisers while generating yield for publisher websites. Taboola competes with Google, Amazon, and other advertising networks that display stories and products on websites. The company was founded in 2007 in Israel. It acquired Connexity, a retail advertising network, in 2021, and entered a partnership with Yahoo in 2022, in which it acquired exclusive native advertising rights over Yahoo digital properties in exchange for a 25% equity stake in the company.
About INMD InMode Ltd.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.